Your session is about to expire
← Back to Search
Remote Monitoring for Diabetic Foot Ulcers
Study Summary
This trial compares two methods to monitor chronic wounds: remote monitoring with a smartphone and in-person clinic visits. 120 patients with diabetic foot ulcers will be enrolled in a 12-week study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am receiving treatment for a wound from a diabetic foot ulcer.I am 18 years old or older.I have wounds in hard-to-reach areas and no one to help me take pictures of them.I change my wound dressing less than once a week.Your wound is too big to be covered by a single picture, like a wound that wraps around your whole leg.
- Group 1: Standard care
- Group 2: Remote wound monitoring technology
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical investigation still taking in participants?
"Based on the current information available from clinicaltrials.gov, this trial is seeking participants. The research was initially posted on December 8th 2022 and has since been updated at least once."
What is the participant size of this clinical research endeavor?
"Yes, the data hosted on clinicaltrials.gov confirms that this research effort is currently enrolling subjects. The study was posted for the first time on December 8th 2022 and has been revised since then with a goal of recruiting 120 patients from one location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger